Journal Article Summary
The article investigates women's experiences with transdermal contraception, specifically a contraceptive patch, focusing on compliance, satisfaction, and preference over a six-month period. This topic is significant as effective contraception is crucial for preventing unintended pregnancies, and understanding user satisfaction can lead to better adherence to contraceptive methods. The transdermal patch offers a convenient alternative to daily oral contraceptives, potentially improving compliance due to its once-weekly application.
In this study, 778 women aged 18 to 46 from eight European countries participated, using the transdermal patch for six cycles of four weeks each. The findings revealed that over 80% of participants reported being satisfied or very satisfied with the patch after three and six cycles, with 73.7% expressing a preference for it compared to their previous contraceptive methods. Compliance was notably high, with 90.5% of recorded cycles completed perfectly, and only two pregnancies occurred during the study, indicating effective use of the patch.
However, the study has limitations, including a lack of diversity in the participant population and potential biases in self-reported satisfaction and compliance. While the patch was generally well tolerated, with most adverse events being mild and temporary, patients should discuss any concerns or side effects with their healthcare provider. It is essential for individuals to consider their personal health needs and preferences when choosing a contraceptive method, and to consult with a healthcare professional for tailored advice.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Jakimiuk AJ, Crosignani PG, Chernev T, Prilepskaya V, Bergmans P, Von Poncet M, Marelli S, Lee EJ. High levels of women's satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study. Gynecological Endocrinology 2011. DOI: 10.3109/09513590.2010.538095. PMID: 21142776. PMCID: PMC3205821.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
